首页> 外文期刊>The Internet Journal of Microbiology >Isolation, characterization and mutagenesis of exopolysaccharide synthesizing new strains of lactic acid bacteria
【24h】

Isolation, characterization and mutagenesis of exopolysaccharide synthesizing new strains of lactic acid bacteria

机译:合成新型乳酸菌菌株的胞外多糖的分离,鉴定和诱变

获取原文
       

摘要

Bacterial exopolysaccharides have wide applications in various industries. In this perspective, it is essential to explore the natural biodiversity for novel strains of exopolysaccharide synthesizing lactic acid bacteria (LAB). Two novel isolates of lactic acid bacteria with higher enzyme activity were screened and characterized based on a battery of microscopic, staining, metabolic, physiological and antibiotic sensitivity tests. The two isolates of LAB named SPO and SPA were cocci shaped, Gram Positive, catalase negative, heterofermentative, vancomycin resistant, broad spectrum carbohydrate fermentating with exopolysaccharide synthesizing activity. EPS synthesizing activity was confirmed by activity staining of EPS using sucrose as substrate. This confirmed that the EPS produced was dextran and the enzyme responsible for its synthesis is dextransucrase. The enzyme activity of SPO was 3.8 U/ml and that of SPA was 3.4 U/ml. For strain improvement, the isolates were subjected to UV radiation. The isolate SPO did not give promising results. However, SPA after UV-mutagenesis, generated two novel mutants, SPAm1 and SPAm2. The enzyme activity of SPAm1 was 4.9 U/ml and that of SPAm2 was 4.7 U/ml. The mutants possessed about 40% enhanced enzyme activity over the wild type strain. Introduction Since time immemorial, lactic acid bacteria are regarded as food grade micro-organisms. LAB have found wide applications as food preservatives, flavouring and texturizing agents for centuries [1] and are now used as starter culture in dairy industry, meat and vegetable fermentation. LAB have received great attention as the major group of probiotic bacteria promoting the growth of gut micro flora [2]. LAB are also reported to cure diarrhoea, irritable bowel disorder, allergies, lactose intolerance, urinary tract infections and to stimulate immunity (3,4,5). LAB capable of secreting antimicrobial peptides are used as food preservatives as well as health-promoting agents for humans [6]. Lactic acid bacteria have attracted immense commercial interests, for their capacity to secrete a host of exopolysaccharides having industrially useful physico-chemical properties [7,8]. Dextrans are a class of exopolysaccharides synthesised by Lactobacillus, Leuconostoc and Streptococcus belonging to LAB family. Sucrose is hydrolysed by the enzyme dextransucrase and the resultant D-glucosyl moieties are polymerised to produce dextran. Dextrans are employed as blood plasma substitutes, plasminogen activators, antithrombogenic agents and in treatment of iron deficiency anaemia [9,10]. Dextrans have also tremendous usage in matrix preparation of chromatography columns [10]. Dextrans have major use in food formulations as stabilizing, emulsifying, texturizing and gelling agent. Dextran is reported to enhance biocompatibility of biomaterials [11]. Considering the grand commercial usage of the dextrans, it is essential to discover novel isolates of LAB synthesizing bioactive exopolysaccharides. It is important to garner sufficient information about the characteristics of the EPS producing strains, as the optimal growth conditions, carbohydrate fermentation ability, antibiotic sensitivity studies have practical implications in maximizing the dextran production on large scale. The development of novel approaches in food and in pharmaceutoclinical therapies is broadening the potential for using lactic acid bacteria. [12]. Apart from screening the biodiversity for selection of new isolates, UV induced mutagenesis of the existing strains for improvement is a promising strategy. UV mutagenesis was carried out on the strains of L. delbrueckii (NCIM 2365) and screened four novel mutants exhibiting higher lactic acid productivity and yield with faster growth rates and shorter lag phases were reported [13]. The present study reports the isolation of two new strains of lactic acid bacteria from the soil samples, their characterization. UV mutagenesis as a tool for strain improvemen
机译:细菌胞外多糖在各种工业中都有广泛的应用。从这个角度出发,探索合成乳酸菌(LAB)的新型胞外多糖菌株的自然生物多样性至关重要。根据一系列的显微镜,染色,代谢,生理和抗生素敏感性测试,筛选并鉴定了具有较高酶活性的两种新型乳酸菌。 LAB的两个分离株分别命名为SPO和SPA,呈球菌形,革兰氏阳性,过氧化氢酶阴性,异源发酵,耐万古霉素,具有外多糖合成活性的广谱碳水化合物发酵。通过使用蔗糖作为底物对EPS进行活性染色来确认EPS的合成活性。这证实了所产生的EPS是葡聚糖,并且负责其合成的酶是葡聚糖转移酶。 SPO的酶活性为3.8U / ml,SPA的酶活性为3.4U / ml。为了改善菌株,使分离物经受UV辐射。分离的SPO没有给出令人满意的结果。但是,在紫外线诱变后,SPA产生了两个新的突变体SPAm1和SPAm2。 SPAm1的酶活性为4.9U / ml,SPAm2的酶活性为4.7U / ml。该突变体具有比野生型菌株高约40%的酶活性。引言自远古时代以来,乳酸菌就被视为食品级微生物。 LAB数百年来一直被广泛用作食品防腐剂,调味剂和膨松剂[1],现在已被用作乳制品行业,肉类和蔬菜发酵中的发酵剂。乳酸菌作为促进肠道菌群生长的主要益生菌群,受到了极大的关注[2]。据报道,LAB还可以治愈腹泻,肠易激惹,过敏,乳糖不耐症,尿路感染和刺激免疫力(3,4,5)。能够分泌抗微生物肽的LAB被用作食品防腐剂以及人类健康促进剂[6]。乳酸菌由于其分泌大量具有工业上有用的理化性质的胞外多糖的能力而引起了巨大的商业兴趣[7,8]。葡聚糖是一类由乳酸菌,乳酸隐球菌和链球菌属的乳酸菌合成的胞外多糖。蔗糖被葡聚糖转葡糖酶水解,所得的D-葡萄糖基部分被聚合生成葡聚糖。葡聚糖被用作血浆替代品,纤溶酶原激活剂,抗血栓形成剂,并用于治疗缺铁性贫血[9,10]。葡聚糖在色谱柱的基质制备中也有大量用途[10]。葡聚糖主要在食品配方中用作稳定剂,乳化剂,膨松剂和胶凝剂。据报道,葡聚糖可增强生物材料的生物相容性[11]。考虑到右旋糖酐在商业上的广泛使用,发现合成生物活性外多糖的LAB的新型分离物至关重要。重要的是,要获得有关EPS产生菌株特性的足够信息,因为最佳的生长条件,碳水化合物的发酵能力,抗生素敏感性研究对大规模扩大右旋糖酐的生产具有实际意义。食品和药物临床疗法中新方法的发展正在拓宽使用乳酸菌的潜力。 [12]。除了筛选生物多样性以选择新的分离物外,现有菌株的紫外线诱变还需要改进。在德氏乳杆菌(NCIM 2365)的菌株上进行了紫外诱变,并筛选出四个新的突变体,这些突变体显示出较高的乳酸生产率和产量,具有更快的生长速率和更短的迟滞期[13]。本研究报告从土壤样品中分离出两种新的乳酸菌菌株,并对其特性进行了表征。紫外线诱变作为改善菌株的工具

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号